Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-15.7%
5Y CAGR+2.5%
Year-over-Year Change
Research and development spending
3Y CAGR
-15.7%/yr
vs +29.5%/yr prior
5Y CAGR
+2.5%/yr
Recent deceleration
Acceleration
-45.2pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.50M | -56.0% |
| 2024 | $26.14M | -4.1% |
| 2023 | $27.27M | +41.9% |
| 2022 | $19.22M | +9.3% |
| 2021 | $17.59M | +73.4% |
| 2020 | $10.14M | +12.7% |
| 2019 | $9.00M | +31.6% |
| 2018 | $6.84M | -27.8% |
| 2017 | $9.47M | +99.3% |
| 2016 | $4.75M | - |